Agios Pharmaceuticals Inc
NASDAQ:AGIO 3:59:59 PM EDT
Earnings Announcements
Agios Reports Business Highlights And First Quarter 2022 Financial Results
Published: 05/05/2022 11:31 GMT
Agios Pharmaceuticals Inc (AGIO) - Agios Reports Business Highlights and First Quarter 2022 Financial Results.
Qtrly Loss per Share $1.74.
Q1 Earnings per Share View $-1.81 -- Refinitiv Ibes Data (analyst estimates).
Qtrly Loss per Share $1.74.
Q1 Earnings per Share View $-1.81 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $2.49 Million
Adjusted EPS is expected to be -$1.69
Next Quarter Revenue Guidance is expected to be $4.99 Million
Next Quarter EPS Guidance is expected to be -$1.69
More details on our Analysts Page.
Adjusted EPS is expected to be -$1.69
Next Quarter Revenue Guidance is expected to be $4.99 Million
Next Quarter EPS Guidance is expected to be -$1.69
More details on our Analysts Page.